Accès ouvert
2022
article
OpenAlex
Rudraraju Srilakshmi Reshma, Samer S. Daher, Ricardo Gallardo‐Macias, Xin Wang et autres
Recent studies have reported the β-ketoacyl-acyl carrier protein KasA as a druggable target for Mycobacterium tuberculosis. This review summarizes the current status of major classes of KasA inhibitors with an emphasis on significant contributions from structure-based design methods leveraging X-ray crystal structures …
us
(code pays fourni par la source)
Accès ouvert
2022
preprint
OpenAlex
Carly Levine, Ravindra D. Jadhav, Yan Pan, Kholiswa Tsotetsi et autres
ABSTRACT Rapid emergence of drug resistance in Mycobacterium tuberculosis (Mtb) is one of the most significant healthcare challenges of our time. The cause of drug resistance is multifactorial, with the long course anti-tubercular therapy required to treat tuberculosis (TB) constituting a major …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Alexander D. Lemenze, Nisha Mittal, Alexander L. Perryman, Samer S. Daher et autres
Rickettsia is a genus of Gram-negative bacteria that has for centuries caused large-scale morbidity and mortality. In recent years, the resurgence of rickettsial diseases as a major cause of pyrexias of unknown origin, bioterrorism concerns, vector movement, and concerns over drug resistance …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Samer S. Daher, Miseon Lee, Xiao Jin, Christiana N. Teijaro et autres
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Samer S. Daher, Miseon Lee, Xiao Jin, Christiana N. Teijaro et autres
Abstract There is an urgent need for new antibiotics to mitigate the existential threat posed by antibiotic resistance. Within the ketolide class, solithromycin has emerged as one of the most promising candidates for further development. Crystallographic studies of bacterial ribosomes and ribosomal …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Jimmy S. Patel, Javiera Norambuena, Hassan Al‐Tameemi, Yong-Mo Ahn et autres
We present the application of Bayesian modeling to identify chemical tools and/or drug discovery entities pertinent to drug-resistant Staphylococcus aureus infections. The quinoline JSF-3151 was predicted by modeling and then empirically demonstrated to be active against in vitro cultured clinical methicillin- and …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Ravindra D. Jadhav, Ricardo Gallardo‐Macias, Gaurav Kumar, Samer S. Daher et autres
We present further study of a subset of carbapenems, arising from a previously reported machine learning approach, with regard to their mouse pharmacokinetic profiling and subsequent study in a mouse model of sub-acute Mycobacterium tuberculosis infection. Pharmacokinetic metrics for such small molecules …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Tyler Scherzi, Elizabeth A. D’Ambrosio, Samer S. Daher, Catherine Leimkuhler Grimes et autres
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Samer S. Daher, Kevin P. Franklin, Tyler Scherzi, Paul M. Dunman et autres
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Janaína Cruz Pereira, Samer S. Daher, Kimberley M. Zorn, Matthew Sherwood et autres
us
(code pays fourni par la source)
2020
article
OpenAlex
Elizabeth Soczewski, Soledad Gori, Daniel Paparini, E. Grasso et autres
Accès ouvert
2019
article
OpenAlex
Samer S. Daher, Xiao Jin, Jimmy S. Patel, Joel S. Freundlich et autres
us
(code pays fourni par la source)